4Teresa C P, Isabel T Z, Juan B L, et al. Tumour markers in lung cancer: does the method of obtaining the cut - off point and reference population influence diagnostic yield? [ J ]. Clinical Biochemistry, 1999, 32:467 - 472. 被引量：1
5Ho Y J, Hsieh J F, Tasi S C, et al. Tissue polypeptide specific antigen and squamous cell carcinoma antigen for early prediction of recurrence in lung squamous cell carcinoma[J] .Lung, 2000, 178:75 - 80. 被引量：1
6Bates J, Rutherford M, Divilly M, et al. Clinical value of CYFRA21- 1, carcinoembryonic antigen and tissue polypeptideantigen in the diagnosis of lung cancer[J ]. Eur Respir J, 1997,10:2535 - 3538. 被引量：1
7Manual D, Antonio T, Marina P, et al. Prognostic significance of serum CA125 antigen assay in patients with non - small cell lung cancer[J ]. Cancer, 1994, 73:1368 - 1376. 被引量：1
8Stieber P, Hasholzneru, Bodenmuller H, et al. CYFRA21-1 a new marking in lungcancer. Cancer 1993;72(3):707 被引量：1
9Robb RL. Conversion of low-affinity interleukin-2 receptors to high-affinity statc following of cell memberancs proc. Nat1 A Cand Sci, USA. 1986;83:3992 被引量：1
10Debus E, Moll R. Franke ww, et al. Immunohistochemical distinction of human carcinomas by cytoderatin typing with monoclonal antibodies. Am J pathol 1984;14:121 被引量：1
9Jemal A, Siegel R, Ward E, et al. Cancer statistics,2007. CA Cancer J Clin ,2007,57:43 - 66. 被引量：1
10Jean-Louis Pujol,Jean Grenier,et al. Serum Fragment of Cytokeratin Subunit 19 Measured by CYFRA 21-1 Immunoradiometric Assay as a Marker of Lung Cancer. CANCER RESEARCH 53. 61 -66. January 1. 1993. 被引量：1
